From: miR-589-5p inhibits MAP3K8 and suppresses CD90+ cancer stem cells in hepatocellular carcinoma
Parameters | CD90Low | CD90High | p Value | |
---|---|---|---|---|
Male/Female | Â | 34/4 | 26/2 | 0.969 |
Age* | Â | 52 (32-75) | 45.5 (32-60) | 0.524 |
HBsAg | Â | Â | Â | Â |
 | Positive | 34 (89.5 %) | 25 (89.3 %) | 1.000 |
 | Negative | 4 (10.5 %) | 3 (10.7 %) | |
AFP | Â | Â | Â | Â |
 | Normal | 14 (36.8 %) | 12 (42.9 %) | 0.629 |
 | High | 24 (63.2 %) | 16 (57.1 %) | |
Vascular Invasion | Â | Â | Â | Â |
 | Positive | 2 (5.3 %) | 9 (32.1 %) | 0.010 |
 | Negative | 36 (94.7 %) | 19 (67.9 %) | |
Tumer Size(cm)* | Â | 4.75 (2-18) | 6.5 (3-16) | 0.077 |
Recurrence | Â | 21 (55.3Â %) | 24 (85.7Â %) | 0.009 |
Edmondson Grade | I/II | 25 (65.8Â %) | 15 (53.6Â %) | 0.315 |
 | III/IV | 13 (34.2 %) | 13 (46.4 %) |